Concepedia

Publication | Open Access

Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real‐world setting

DOIFull Paper Access

43

Citations

18

References

2019

Year

Takuya Sho, Goki Suda, Koji Ogawa, Megumi Kimura, Tomoe Shimazaki, Osamu Maehara, Taku Shigesawa, Kazuharu Suzuki, Akihisa Nakamura, Masatsugu Ohara,
JGH Open

Abstract

Lenvatinib showed high early response rate and tolerability in patients with advanced HCC. Favorable outcomes were similarly observed in patients who did not meet the REFLECT inclusion criteria.

References

YearCitations

Page 1